Related Experiment Video
Updated: Jun 15, 2025

12:09
A Novel High-resolution In vivo Imaging Technique to Study the Dynamic Response of Intracranial Structures to Tumor Growth and Therapeutics
Published on: June 16, 2013
11.5K
In Vivo Tracking and 3D Mapping of Cell Death in Regeneration and Cancer Using Trypan Blue
Nicole Procel1, Karen Camacho1, Elisabeth Verboven2,3
1Cancer Research Group, Faculty of Engineering and Applied Sciences, Universidad de Las Américas, Quito 170124, Ecuador.
Cells
|August 28, 2024
Summary
This study introduces Trypan Blue (TBlue) as a novel in vivo cell death marker. TBlue enables sensitive detection and tracking of dying cells, advancing research in tissue homeostasis and disease.
Area of Science:
- Cell Biology
- Biomedical Imaging
- Pathology
Background:
- In vivo cell death tracking is crucial for understanding tissue homeostasis and disease.
- Existing methods for labeling dead cells in vivo have limitations, including poor sensitivity, tissue penetration, and temporal resolution.
Purpose of the Study:
- To develop and validate a novel fluorescent marker, Trypan Blue (TBlue), for sensitive and selective in vivo cell death detection.
- To demonstrate TBlue's utility in various biological contexts, including organ regeneration and preclinical cancer therapy assessment.
Main Methods:
- Fluorescent labeling of dead cells in vivo using Trypan Blue (TBlue).
- Application of TBlue for detecting single dead cells and mapping necrotic tissue in organ regeneration models.
- Utilizing TBlue for "pulse and chase" tracking of dying cells in regenerating mouse livers.
- Assessing TBlue's efficacy in labeling dead cancer cells and chemotherapy-induced cell death in preclinical models.
Main Results:
- TBlue effectively labeled diverse cell death types (necrosis, apoptosis) in various organs (liver, skin).
- TBlue enabled high-resolution 3D mapping of necrotic tissue during organ regeneration.
- The "pulse and chase" approach with TBlue allowed temporal tracking of dying hepatocytes.
- TBlue demonstrated utility in evaluating anticancer therapies by labeling dead cancer cells and chemotherapy-affected thymocytes.
Conclusions:
- Trypan Blue (TBlue) is a sensitive and selective marker for in vivo cell death detection.
- TBlue offers significant advantages over existing methods, including improved sensitivity, tissue penetration, and temporal resolution.
- TBlue facilitates a deeper understanding of cell death's role in normal biological processes and disease, with applications in preclinical research.

